Dr. Srinivas S. Bollimpalli, MD

Dr. Bollimpalli practices at Indiana University Health Arnett Hospital in Lafayette, Indiana, part of Indiana University Health.

Dr. Bollimpalli's NPI, 1205806940, was assigned on January 25, 2006. Dr. Bollimpalli holds Arizona license 27497.

Dr. Bollimpalli's primary practice is Indiana University Health Arnett Hospital, at 5165 McCarty Ln, Lafayette, IN 47905 in Tippecanoe County. The practice phone is (765) 448-8000.

Dr. Bollimpalli's primary practice is Indiana University Health Arnett Hospital in Lafayette, Indiana, part of Indiana University Health. Dr. Bollimpalli is also affiliated with Strong Memorial Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Bollimpalli to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bollimpalli practices, 7 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Bollimpalli's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dmand AI has Dr. Bollimpalli's licenses on file in 3 states: Arizona, Illinois and Maine.

CMS data shows 84 Medicare services from Dr. Bollimpalli across 5 procedure codes in 2024, for 177 Medicare patients. Medicare paid $10,792 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 177 Medicare patients who saw Dr. Bollimpalli in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bollimpalli's median patient age at 62, with 55% women.

In 2018, Dr. Bollimpalli wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $122 in total drug cost. In 2017, CMS named 861 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Bollimpalli for performance year 2024, reported as part of a group. Dr. Bollimpalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 160 general payments to Dr. Bollimpalli from 27 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 97% of the total. Medtronic USA, Inc. paid the most, $804.